Latest Cormorant Asset Management, LP Stock Portfolio
$2.28Billion
Equity Portfolio Value
Last Reported on: 15 May, 2024
About Cormorant Asset Management, LP and it’s 13F Hedge Fund Stock Holdings
Cormorant Asset Management, LP is a hedge fund based in BOSTON, MA. On 31-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $3.1 Billions. In it's latest 13F Holdings report, Cormorant Asset Management, LP reported an equity portfolio of $2.3 Billions as of 31 Mar, 2024.
The top stock holdings of Cormorant Asset Management, LP are MLTX, EYPT, ACLX. The fund has invested 18.7% of it's portfolio in MOONLAKE IMMUNOTHERAPEUTICS and 6.2% of portfolio in EYEPOINT PHARMACEUTICALS INC.
The fund managers got completely rid off AMBRX BIOPHARMA INC (AMAM), RAYZEBIO INC and IMMUNOVANT INC (IMVT) stocks. They significantly reduced their stock positions in SPYRE THERAPEUTICS INC (AGLE), STOKE THERAPEUTICS INC (STOK) and APELLIS PHARMACEUTICALS INC (APLS). Cormorant Asset Management, LP opened new stock positions in CORBUS PHARMACEUTICALS HLDGS (CRBP), NEWAMSTERDAM PHARMA COMPANY (NAMS) and CG ONCOLOGY INC. The fund showed a lot of confidence in some stocks as they added substantially to BIOHAVEN LTD, PRAXIS PRECISION MEDICINES I (PRAX) and LONGBOARD PHARMACEUTICALS IN (LBPH).
The top stock holdings of Cormorant Asset Management, LP are MLTX, EYPT, ACLX. The fund has invested 18.7% of it's portfolio in MOONLAKE IMMUNOTHERAPEUTICS and 6.2% of portfolio in EYEPOINT PHARMACEUTICALS INC.
The fund managers got completely rid off AMBRX BIOPHARMA INC (AMAM), RAYZEBIO INC and IMMUNOVANT INC (IMVT) stocks. They significantly reduced their stock positions in SPYRE THERAPEUTICS INC (AGLE), STOKE THERAPEUTICS INC (STOK) and APELLIS PHARMACEUTICALS INC (APLS). Cormorant Asset Management, LP opened new stock positions in CORBUS PHARMACEUTICALS HLDGS (CRBP), NEWAMSTERDAM PHARMA COMPANY (NAMS) and CG ONCOLOGY INC. The fund showed a lot of confidence in some stocks as they added substantially to BIOHAVEN LTD, PRAXIS PRECISION MEDICINES I (PRAX) and LONGBOARD PHARMACEUTICALS IN (LBPH).
New Buys
| Ticker | $ Bought |
|---|---|
| CORBUS PHARMACEUTICALS HLDGS | 79,461,000 |
| NEWAMSTERDAM PHARMA COMPANY | 35,475,000 |
| CG ONCOLOGY INC | 35,120,000 |
| MERUS N V | 32,196,400 |
| HELIX ACQUISITION CORP II | 30,253,600 |
| TOURMALINE BIO INC | 28,625,000 |
| JANUX THERAPEUTICS INC | 28,237,500 |
| ARCUTIS BIOTHERAPEUTICS INC | 21,058,800 |
New stocks bought by Cormorant Asset Management, LP
Additions
| Ticker | % Inc. |
|---|---|
| BIOHAVEN LTD | 652 |
| PRAXIS PRECISION MEDICINES I | 106 |
| LONGBOARD PHARMACEUTICALS IN | 42.5 |
| AUTOLUS THERAPEUTICS PLC | 21.41 |
| EDGEWISE THERAPEUTICS INC | 17.81 |
| EYEPOINT PHARMACEUTICALS INC | 14.16 |
| ALPINE IMMUNE SCIENCES INC | 5.88 |
| ARCELLX INC | 4.71 |
Additions to existing portfolio by Cormorant Asset Management, LP
Reductions
| Ticker | % Reduced |
|---|---|
| SPYRE THERAPEUTICS INC | -73.32 |
| STOKE THERAPEUTICS INC | -60.73 |
| APELLIS PHARMACEUTICALS INC | -36.00 |
| ROCKET PHARMACEUTICALS INC | -33.33 |
| NEUROGENE INC | -27.8 |
| IMMUNEERING CORP | -21.62 |
| AEROVATE THERAPEUTICS INC | -11.71 |
| BRIDGEBIO PHARMA INC | -4.22 |
Cormorant Asset Management, LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| AMBRX BIOPHARMA INC | -159,929,000 |
| OLEMA PHARMACEUTICALS INC | -34,468,900 |
| HARPOON THERAPEUTICS INC | -22,550,900 |
| CYMABAY THERAPEUTICS INC | -42,516,000 |
| RAYZEBIO INC | -75,441,900 |
| SYNDAX PHARMACEUTICALS INC | -25,391,800 |
| IMMUNOVANT INC | -49,081,400 |
| AXONICS INC | -15,557,500 |
Cormorant Asset Management, LP got rid off the above stocks
Current Stock Holdings of Cormorant Asset Management, LP
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ACLX | ARCELLX INC | 5.43 | 1,780,000 | 123,799,000 | ADDED | 4.71 | |
| AGLE | SPYRE THERAPEUTICS INC | 0.42 | 250,000 | 9,482,500 | REDUCED | -73.32 | |
| ALPN | ALPINE IMMUNE SCIENCES INC | 4.70 | 2,700,000 | 107,028,000 | ADDED | 5.88 | |
| ALXO | ALX ONCOLOGY HLDGS INC | 1.54 | 3,142,080 | 35,034,200 | UNCHANGED | 0.00 | |
| AMAM | AMBRX BIOPHARMA INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| APLS | APELLIS PHARMACEUTICALS INC | 1.03 | 400,000 | 23,512,000 | REDUCED | -36.00 | |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 0.92 | 2,125,000 | 21,058,800 | NEW | ||
| ATXS | ASTRIA THERAPEUTICS INC | 0.80 | 1,300,000 | 18,297,500 | NEW | ||
| AUTL | AUTOLUS THERAPEUTICS PLC | 1.85 | 6,616,670 | 42,214,300 | ADDED | 21.41 | |
| AVTE | AEROVATE THERAPEUTICS INC | 1.39 | 1,069,800 | 31,633,900 | REDUCED | -11.71 | |
| AXNX | AXONICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| BBIO | BRIDGEBIO PHARMA INC | 4.34 | 3,203,030 | 99,037,700 | REDUCED | -4.22 | |
| BCAB | BIOATLA INC | 0.18 | 1,170,870 | 4,027,790 | REDUCED | -0.87 | |
| BMEA | BIOMEA FUSION INC | 2.34 | 3,570,870 | 53,384,500 | UNCHANGED | 0.00 | |
| CABA | CABALETTA BIO INC | 0.82 | 1,100,000 | 18,766,000 | NEW | ||
| CBAY | CYMABAY THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| CMPX | COMPASS THERAPEUTICS INC | 0.48 | 5,560,300 | 11,009,400 | NEW | ||
| CNTA | CENTESSA PHARMACEUTICALS PLC | 0.28 | 561,600 | 6,346,080 | UNCHANGED | 0.00 | |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 3.49 | 2,025,000 | 79,461,000 | NEW | ||
| CRNX | CRINETICS PHARMACEUTICALS IN | 2.36 | 1,150,000 | 53,831,500 | UNCHANGED | 0.00 | |
| EWTX | EDGEWISE THERAPEUTICS INC | 2.41 | 3,006,530 | 54,839,200 | ADDED | 17.81 | |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 6.25 | 6,893,240 | 142,483,000 | ADDED | 14.16 | |
| GHRS | GH RESEARCH PLC | 0.28 | 593,043 | 6,321,840 | UNCHANGED | 0.00 | |
| HARP | HARPOON THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| IDYA | IDEAYA BIOSCIENCES INC | 0.87 | 450,000 | 19,746,000 | UNCHANGED | 0.00 | |
| IMRX | IMMUNEERING CORP | 0.42 | 3,295,270 | 9,523,340 | REDUCED | -21.62 | |
| IMVT | IMMUNOVANT INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| INSM | INSMED INC | 0.68 | 575,000 | 15,599,800 | UNCHANGED | 0.00 | |
| JANX | JANUX THERAPEUTICS INC | 1.24 | 750,000 | 28,237,500 | NEW | ||
| LBPH | LONGBOARD PHARMACEUTICALS IN | 3.18 | 3,353,140 | 72,427,800 | ADDED | 42.5 | |
| LNTH | LANTHEUS HLDGS INC | 0.20 | 75,000 | 4,668,000 | UNCHANGED | 0.00 | |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 18.72 | 8,494,150 | 426,661,000 | UNCHANGED | 0.00 | |
| MRNS | MARINUS PHARMACEUTICALS INC | 1.29 | 3,250,000 | 29,380,000 | UNCHANGED | 0.00 | |
| MRSN | MERSANA THERAPEUTICS INC | 0.51 | 2,600,000 | 11,648,000 | NEW | ||
| MRUS | MERUS N V | 1.41 | 715,000 | 32,196,400 | NEW | ||
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 1.56 | 1,500,000 | 35,475,000 | NEW | ||
| NKTX | NKARTA INC | 0.64 | 1,350,000 | 14,593,500 | NEW | ||
| OLMA | OLEMA PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| PCVX | VAXCYTE INC | 2.05 | 685,000 | 46,792,400 | ADDED | 3.01 | |
| PHVS | PHARVARIS N V | 1.74 | 1,711,460 | 39,551,800 | UNCHANGED | 0.00 | |
| PRAX | PRAXIS PRECISION MEDICINES I | 3.51 | 1,310,000 | 79,936,200 | ADDED | 106 | |
| RAPT | RAPT THERAPEUTICS INC | 0.20 | 496,750 | 4,460,820 | UNCHANGED | 0.00 | |
| RCKT | ROCKET PHARMACEUTICALS INC | 0.36 | 300,000 | 8,082,000 | REDUCED | -33.33 | |
| RYTM | RHYTHM PHARMACEUTICALS INC | 1.04 | 550,000 | 23,831,500 | UNCHANGED | 0.00 | |
| SLN | SILENCE THERAPEUTICS PLC | 0.59 | 625,000 | 13,500,000 | NEW | ||
| SNDX | SYNDAX PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| STOK | STOKE THERAPEUTICS INC | 0.25 | 427,163 | 5,766,700 | REDUCED | -60.73 | |
| TARS | TARSUS PHARMACEUTICALS INC | 3.41 | 2,139,100 | 77,756,400 | REDUCED | -3.71 | |
| VERV | VERVE THERAPEUTICS INC | 0.20 | 350,000 | 4,648,000 | UNCHANGED | 0.00 | |
| VTYX | VENTYX BIOSCIENCES INC | 0.65 | 2,710,000 | 14,905,000 | NEW | ||
| VYNE | VYNE THERAPEUTICS INC | 0.19 | 1,394,340 | 4,280,610 | UNCHANGED | 0.00 | |
| KORRO BIO INC | 2.09 | 529,170 | 47,625,300 | UNCHANGED | 0.00 | ||
| CG ONCOLOGY INC | 1.54 | 800,000 | 35,120,000 | NEW | |||
| BIOHAVEN LTD | 1.48 | 616,963 | 33,741,700 | ADDED | 652 | ||
| ABIVAX SA | 1.34 | 2,130,000 | 30,459,000 | UNCHANGED | 0.00 | ||
| HELIX ACQUISITION CORP II | 1.33 | 2,909,000 | 30,253,600 | NEW | |||
| TOURMALINE BIO INC | 1.26 | 1,250,000 | 28,625,000 | NEW | |||
| NEUROGENE INC | 1.20 | 538,714 | 27,420,500 | REDUCED | -27.8 | ||
| CARGO THERAPEUTICS INC | 1.16 | 1,182,560 | 26,394,800 | UNCHANGED | 0.00 | ||
| ENGENE HOLDINGS INC | 0.74 | 1,000,000 | 16,950,000 | NEW | |||
| KYVERNA THERAPEUTICS INC | 0.48 | 440,000 | 10,929,600 | NEW | |||
| ARRIVENT BIOPHARMA INC | 0.40 | 515,000 | 9,197,900 | NEW | |||
| DISC MEDICINE INC | 0.34 | 125,000 | 7,782,500 | UNCHANGED | 0.00 | ||
| NEUMORA THERAPEUTICS INC. | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | ||
| RAYZEBIO INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 |